Do social values and institutional context shape the use of economic evaluation in reimbursement decisions? An empirical analysis A Torbica, G Fornaro, R Tarricone, MF Drummond Value in Health 23 (1), 17-24, 2020 | 28 | 2020 |
Broadening the concept of value: a scoping review on the option value of medical technologies G Fornaro, C Federici, C Rognoni, O Ciani Value in Health 24 (7), 1045-1058, 2021 | 19 | 2021 |
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer … P Armeni, L Borsoi, G Fornaro, C Jommi, F Grossi, F Costa Clinical therapeutics 42 (5), 830-847, 2020 | 17 | 2020 |
Cost-effectiveness and net monetary benefit of olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed … P Armeni, L Borsoi, G Fornaro, C Jommi, N Colombo, F Costa Clinical therapeutics 42 (7), 1192-1209. e12, 2020 | 10 | 2020 |
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? M Drummond, O Ciani, G Fornaro, C Jommi, ES Dietrich, J Espin, ... BMC health services research 23 (1), 484, 2023 | 7 | 2023 |
Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome C Federici, G Fornaro, CC Roehr European Journal of Hospital Pharmacy 29 (6), 346-352, 2022 | 5 | 2022 |
The impact of surgical experience in VATS lobectomy on conversion and patient quality of life: Results from a comprehensive national video-assisted thoracic surgical database L Bertolaccini, G Fornaro, O Ciani, E Prisciandaro, R Crisci, R Tarricone, ... Cancers 15 (2), 410, 2023 | 3 | 2023 |
Value-based healthcare: Il nuovo approccio di AIFA alla determinazione multidimensionale del valore O Ciani, C Federici, G Fornaro, C Rognoni Global & Regional Health Technology Assessment 7, 9, 2020 | 2 | 2020 |
The Value of Hearing Aids for the Italian NHS: A Cost-utility Analysis G Fornaro, P Armeni, A Albera, M Barbara Otology & Neurotology Open 2 (4), e018, 2022 | | 2022 |
P48 Are Health Technology Assessment (HTA) Bodies Responding to the Assessment Challenges Posed By Cell and Gene Therapies? G Fornaro, M Drummond, O Ciani, C Jommi Value in Health 25 (7), S297, 2022 | | 2022 |
CP2 DO SOCIAL VALUES AND INSTITUTIONAL CONTEXT IMPACT THE USE OF ECONOMIC EVALUATION IN PRIORITY SETTING: EMPIRICAL EVIDENCE FROM OECD COUNTRIES A Torbica, G Fornaro, R Tarricone, M Drummond Value in Health 22, S408, 2019 | | 2019 |
FEATURED CONTENT P Armeni, L Borsoi, G Fornaro, C Jommi, N Colombo, F Costa, ... | | |